Purchase Order HHSN261201500413P
Award Date 9/17/15
Potential Completion Date 9/20/16
Potential Value $146K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Israel
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian federal agency, to The Gertner Institute for Epidemiology & Health Policy Research LTD, a non-profit organization located in Israel. The $304,823.00 contract is for services to collect exposure information and covariate data from paper and electronic clinic records from 16 in vitro fertilization (IVF) clinics. The base period of performance is 1 year with 1 option year. The contract does...
- The National Cancer Institute (NCI), within the Department of Health and Human Services, awarded a $636,321 firm fixed price delivery order to GU Rnpts Rmiech, a Belarusian government research entity, on February 15, 2024. This delivery order, which extends through November 14, 2033, supports cohort maintenance and linkage services for ongoing epidemiological research examining cancer and other health effects among populations exposed to radiation from the 1986 Chernobyl nuclear accident. The...
- <p>The National Cancer Institute issued a delivery order to Palladian Partners, Inc. on February 27, 2018, for branding of a new epidemiological study of cancer, with a ceiling value of $69,915.17.</p> <p>The order was issued under the NIH Public Information and Communication 2012–2016 indefinite-delivery contract. Place of performance is Silver Spring, MD. The order is firm fixed price with an ultimate completion date of May 31, 2019.</p>
- The National Cancer Institute issued a delivery order to the Institute for Defense Analyses on September 15, 2014, with a ceiling value of $148,946.92 for the development of evaluation metrics for extramurally funded programs, projects, and initiatives for the Epidemiology and Genomics Research Program. Place of performance is Alexandria, VA. The period of performance runs from September 15, 2014, through December 31, 2017. The order is priced on a cost-plus-fixed-fee basis with no set-aside...
- The National Cancer Institute awarded a purchase order to Outcomes Insights, Inc. for $24,680.00 on August 3, 2015. The order funds extraction, transformation, and loading of Surveillance, Epidemiology, and End Results (SEER) breast cancer data into the Observational Medical Outcomes Partnership (OMOP) Common Data Model in support of the Division of Cancer Control and Population Sciences' Surveillance Informatics Branch. Work is performed in Westlake Village, California, under a firm fixed-price...
- <p>The National Cancer Institute issued a purchase order to National Cancer Center, National Research and Development Agency on May 14, 2026, with a ceiling value of $15,075.00 for firm fixed price commercial items. This order replaces PO 75N91021P00879 to correct the UEI number. Work is performed in Bethesda, Maryland, with an ultimate completion date of May 13, 2027.</p>
- The National Cancer Institute issued a delivery order to the Department of Public Health Connecticut on August 15, 2014, with a ceiling value of $47,682.81 for the Patterns of Care/Quality of Care Study covering diagnosis year 2013 under the Surveillance, Epidemiology, and End Results (SEER) Program. The order runs from August 15, 2014, through August 14, 2015. Work is performed in Hartford, Connecticut. This is a cost, no-fee delivery order supporting SEER data collection and analysis...
- The National Cancer Institute awarded a purchase order to Department of Health for $13,048.57 on September 20, 2017, to conduct research on nitrates, 5-alpha-reductase inhibitors, and hormone replacement therapy and their relationship to gastrointestinal cancer risk. Work was performed in Rockville, Maryland under a firm fixed price arrangement. The period of performance ran from September 21, 2017 through September 20, 2018. The awardee, the United Kingdom's Department of Health (doing business...
- <p>The National Cancer Institute awarded a purchase order to Metastat, Inc. for $46,600 on September 21, 2016. The order covers services to examine and analyze MENA signatures within a case-control study of patients with ER-positive breast cancer. Work is performed in Rockville, Maryland. The ultimate completion date is March 25, 2021. This purchase order represents a de-obligation of funds from FY2016 expiring lines.</p>
- The National Cancer Institute issued a delivery order to the Institute for Defense Analyses on September 15, 2014, for implementation of the NCI Community Oncology Research Program (NCORP), with a ceiling value of $435,969.83. This is a cost-plus-fixed-fee delivery order with no set-aside. The period of performance extends through August 30, 2018, following a no-cost extension that added two months to the original timeline. Place of performance is Alexandria, VA. The total funded amount...